104 related articles for article (PubMed ID: 3574223)
1. Misleading advertising.
Bridge DT
Med J Aust; 1987 Feb; 146(4):229-30. PubMed ID: 3574223
[No Abstract] [Full Text] [Related]
2. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
[No Abstract] [Full Text] [Related]
3. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
Dubnitskaia LV; Sotnikova EI
Akush Ginekol (Mosk); 1990 Apr; (4):57-60. PubMed ID: 1696071
[TBL] [Abstract][Full Text] [Related]
4. Oral contraception, 1986. Currently available formulations.
Hale R
J Reprod Med; 1986 Jun; 31(6 Suppl):557-8. PubMed ID: 3088272
[TBL] [Abstract][Full Text] [Related]
5. Oral contraception with a biphasic tablet (observations with anteovin).
Tallián F
Ther Hung; 1986; 34(2):112-6. PubMed ID: 3449970
[No Abstract] [Full Text] [Related]
6. Use of biphasic cyclic hormone therapy in functional bleeding disorders of adolescents (Anteovin).
Kis-Csitári I
Ther Hung; 1988; 36(2):73-6. PubMed ID: 3201389
[No Abstract] [Full Text] [Related]
7. Observations with anteovin "step-up" contraceptive tablet in young women.
Takács G; Hámori M
Ther Hung; 1986; 34(3):150-4. PubMed ID: 3441877
[No Abstract] [Full Text] [Related]
8. Less estrogen in new oral contraceptive.
Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
[No Abstract] [Full Text] [Related]
9. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
10. [Use of Ovidon, Rigevidon and Postinor for contraception].
Kulakov VI; Barinov AM; Prilepskaia VN
Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
[No Abstract] [Full Text] [Related]
11. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
Hampton RM; Fisher AC; Pagano S; LaGuardia KD
Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
[TBL] [Abstract][Full Text] [Related]
12. Oral contraception, 1986. Focus on Triphasil.
Ellsworth H
J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
[TBL] [Abstract][Full Text] [Related]
13. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
[TBL] [Abstract][Full Text] [Related]
14. Confusion between oral contraceptives and oestrogen replacement preparations.
Levinsohn DG
S Afr Med J; 1988 Jul; 74(2):89. PubMed ID: 3399985
[No Abstract] [Full Text] [Related]
15. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
Urdinola J
Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
[No Abstract] [Full Text] [Related]
16. "Estrophasic" dosing: A new concept in oral contraceptive therapy.
Rowan JP
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 2):302-6. PubMed ID: 9988834
[TBL] [Abstract][Full Text] [Related]
17. [Low dose p-pills, Gynatrol and Mikrogyn].
Falck Larsen J
Ugeskr Laeger; 1976 Sep; 138(40):2446-7. PubMed ID: 969002
[No Abstract] [Full Text] [Related]
18. Use of triphasic Tri-Regol tablet in women of borderline age.
Takács G
Ther Hung; 1991; 39(4):188-91. PubMed ID: 1811332
[TBL] [Abstract][Full Text] [Related]
19. Alopecia related to low dose oral contraceptive.
Yokoyama Y; Sato S; Saito Y
Arch Gynecol Obstet; 2002 Jan; 266(1):46-7. PubMed ID: 11998965
[TBL] [Abstract][Full Text] [Related]
20. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Christie T
J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
